← SynDRA
MLN-8054
SynDRA canonical compound SYN0008922 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AURKA |
|---|
| Mechanism of action | Protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Mitotic inhibitor
- aurora kinase inhibitor
- Protein kinase inhibitor
- AURKA INHIBITOR
- Serine/threonine-protein kinase Aurora-A inhibitor
- AURKB INHIBITOR
Cross-references
Synonyms
- MLN 8054
- Mln8054
- MLN8054
- ZZL
- BX854EHD63
- RefChem:819035
- DTXCID40158478
- Aurora Kinase Inhibitor MLN8054
- UNII-BX854EHD63
- C25H15ClF2N4O2
- MFCD11840561
- Kinome_1204
- MLS006011043
- SCHEMBL621589
- GTPL5696
- orb1300877
- SCHEMBL29372555
- SCHEMBL29720492
- BDBM31093
- CHEBI:91366
- cid_11712649
- MLN 8054 [WHO-DD]
- HMS3265K23
- HMS3265K24
- HMS3265L23
- HMS3265L24
- HMS3654C21
- MLN8054?
- EBC-11409
- NSC800799
- s1100
- AKOS022177375
- CCG-269512
- CS-0010
- FM26029
- NSC-800799
- SB19104
- SDCCGSBI-0654442.P001
- NCGC00346488-01
Look up MLN-8054 in the interactive SynDRA portal →